Cargando…
Local ablative radiotherapy for oligometastatic non-small cell lung cancer
In metastatic non-small cell lung cancer (NSCLC), the role of radiotherapy (RT) has been limited to palliation to alleviate the symptoms. However, with the development of advanced RT techniques, recent advances in immuno-oncology therapy targeting programmed death 1 (PD-1) and programmed death ligan...
Autores principales: | Suh, Yang-Gun, Cho, Jaeho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Radiation Oncology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790793/ https://www.ncbi.nlm.nih.gov/pubmed/31591862 http://dx.doi.org/10.3857/roj.2019.00514 |
Ejemplares similares
-
Role of local ablative treatment in oligometastatic non-small cell lung cancer: a meta-analysis
por: Rim, Chai Hong, et al.
Publicado: (2023) -
Results of Radiation Therapy as Local Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer
por: Billing, David L., et al.
Publicado: (2021) -
The Role of Stereotactic Ablative Radiotherapy for Early-Stage and Oligometastatic Non-small Cell Lung Cancer: Evidence for Changing Paradigms
por: Dahele, Max, et al.
Publicado: (2011) -
Local Consolidative Therapy for Oligometastatic Non-Small Cell Lung Cancer
por: Santos, Patricia Mae G., et al.
Publicado: (2022) -
Radiotherapy for oligometastatic non-small cell lung cancer: a narrative review
por: Sundahl, Nora, et al.
Publicado: (2021)